Definitive Healthcare Corp. (NASDAQ:DH) Given Consensus Rating of “Hold” by Brokerages

Shares of Definitive Healthcare Corp. (NASDAQ:DH) have been given an average rating of “Hold” by the eleven analysts that are presently covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and three have given a buy recommendation to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $5.72.

A number of equities analysts recently commented on the stock. Needham & Company LLC reaffirmed a “hold” rating on shares of Definitive Healthcare in a research report on Thursday, January 16th. Stephens started coverage on shares of Definitive Healthcare in a report on Friday, December 20th. They set an “equal weight” rating and a $5.00 target price on the stock. Finally, Barclays reiterated an “underweight” rating and issued a $4.00 price target on shares of Definitive Healthcare in a research note on Monday, January 13th.

Definitive Healthcare Price Performance

Definitive Healthcare stock opened at $4.71 on Thursday. The company has a market capitalization of $544.10 million, a price-to-earnings ratio of -1.52, a PEG ratio of 2.96 and a beta of 1.41. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33. Definitive Healthcare has a 12 month low of $3.19 and a 12 month high of $10.62. The stock’s 50 day moving average is $4.34 and its 200-day moving average is $4.47.

Definitive Healthcare (NASDAQ:DH) last issued its quarterly earnings data on Thursday, November 7th. The company reported $0.05 EPS for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.03). Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. The firm had revenue of $62.70 million during the quarter, compared to analyst estimates of $61.66 million. During the same period in the prior year, the company earned $0.01 earnings per share. Equities research analysts expect that Definitive Healthcare will post 0.15 EPS for the current year.

Insider Buying and Selling at Definitive Healthcare

In other news, insider William Moschella sold 45,000 shares of the stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total value of $211,500.00. Following the completion of the transaction, the insider now owns 433,830 shares of the company’s stock, valued at approximately $2,039,001. This represents a 9.40 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 14.84% of the company’s stock.

Hedge Funds Weigh In On Definitive Healthcare

A number of institutional investors have recently added to or reduced their stakes in the stock. Nisa Investment Advisors LLC boosted its stake in shares of Definitive Healthcare by 3,652.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 6,980 shares of the company’s stock valued at $29,000 after purchasing an additional 6,794 shares in the last quarter. Point72 DIFC Ltd raised its holdings in Definitive Healthcare by 759.9% in the 3rd quarter. Point72 DIFC Ltd now owns 9,296 shares of the company’s stock valued at $42,000 after buying an additional 8,215 shares during the last quarter. Intech Investment Management LLC acquired a new stake in Definitive Healthcare during the 3rd quarter worth approximately $55,000. Bleakley Financial Group LLC bought a new stake in Definitive Healthcare during the 3rd quarter worth approximately $74,000. Finally, Glenmede Trust Co. NA grew its holdings in Definitive Healthcare by 41.1% during the 3rd quarter. Glenmede Trust Co. NA now owns 18,423 shares of the company’s stock worth $82,000 after acquiring an additional 5,362 shares during the last quarter. 98.67% of the stock is currently owned by institutional investors and hedge funds.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.